Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 623

Results For "AP"

6626 News Found

Max Ventilator forms partnership with US-based Amptron Medical
Drug Approval | September 07, 2021

Max Ventilator forms partnership with US-based Amptron Medical

Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.


Anti-dumping duty proposed on Vitamin C from China for five years
News | September 07, 2021

Anti-dumping duty proposed on Vitamin C from China for five years

The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports


Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19
Drug Approval | September 06, 2021

Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19

Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence


TB Alliance partners with Lupin for non-exclusive anti-TB drug
Policy | September 06, 2021

TB Alliance partners with Lupin for non-exclusive anti-TB drug

According to WHO, over 1.5 million people died of TB in 2020


CRAMS to drive growth for Indian pharma industry: report
News | September 06, 2021

CRAMS to drive growth for Indian pharma industry: report

The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion


NF Healthcare launch latest version of its oxygen generators
Healthcare | September 06, 2021

NF Healthcare launch latest version of its oxygen generators

The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour


Dr Reddy’s enters agreement with Citius to sell rights of its anti-cancer agent
Drug Approval | September 04, 2021

Dr Reddy’s enters agreement with Citius to sell rights of its anti-cancer agent

In March 2016, Dr. Reddy’s had acquired the exclusive global rights (excluding Japan and Asia) to the investigational anti-cancer agent E7777 from Eisai Co.


Govt revises NLEM and slashes prices of 39 drugs
Policy | September 04, 2021

Govt revises NLEM and slashes prices of 39 drugs

At present 18 per cent of the local pharmaceutical market is under government's price control


Reliance Strategic Business Ventures acquires Strand Life Sciences for Rs 393 crores
Drug Approval | September 04, 2021

Reliance Strategic Business Ventures acquires Strand Life Sciences for Rs 393 crores

The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India


HCG acquires oncology labs and divests stake in Strand Life Sciences
Healthcare | September 04, 2021

HCG acquires oncology labs and divests stake in Strand Life Sciences

The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business